Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009 Mar;379(3):291-303.
doi: 10.1007/s00210-008-0359-7. Epub 2008 Oct 15.

Combined effect of protein kinase B inhibitor or extracellular signal-regulated kinase inhibitor against farnesyltransferase inhibition-induced apoptosis in SiHa cells

Affiliations

Combined effect of protein kinase B inhibitor or extracellular signal-regulated kinase inhibitor against farnesyltransferase inhibition-induced apoptosis in SiHa cells

Sun Joo Lee et al. Naunyn Schmiedebergs Arch Pharmacol. 2009 Mar.

Abstract

The present study investigated the combined effect of Akt or extracellular signal-regulated kinase (ERK) inhibition in the presence of farnesyltransferase inhibitor against human cervix and uterus tumor cell line SiHa cells. Farnesyltransferase inhibitor may induce apoptosis through the mitochondria-mediated process and inhibition of the MEK, ERK, and Akt activity. Inhibitors of Akt and ERK at low concentrations seem to prevent the farnesyltransferase inhibitor-induced apoptosis in cervical SiHa cells by suppressing the mitochondrial membrane permeability change that leads to cytochrome c release and caspase-3 activation. These effects may be associated with inhibition of the reactive oxygen species formation and glutathione depletion. In contrast, at higher concentrations more than 1 microM, the Akt inhibitor and ERK inhibitor seem to exhibit an additive toxic effect against farnesyltransferase inhibitor-induced apoptosis by increasing mitochondrial membrane permeability change and oxidative stress, which may not involve inhibition of MEK, ERK, and Akt activity.

PubMed Disclaimer

Similar articles

References

    1. Biochem Biophys Res Commun. 2004 Jul 23;320(2):493-500 - PubMed
    1. Front Biosci. 2002 Feb 01;7:d376-89 - PubMed
    1. Eur J Clin Invest. 1999 Mar;29(3):238-45 - PubMed
    1. Recent Results Cancer Res. 2007;172:125-53 - PubMed
    1. J Neurosci Res. 2006 Nov 1;84(6):1367-75 - PubMed

MeSH terms

LinkOut - more resources